Name | Value |
---|---|
Revenues | 632.1M |
Cost of Revenue | 296.4M |
Gross Profit | 335.7M |
Operating Expense | 244.7M |
Operating I/L | 90.9M |
Other Income/Expense | 58.6M |
Interest Income | 17.3M |
Pretax | 137.1M |
Income Tax Expense | 30.8M |
Net Income/Loss | 106.3M |
Bio-Rad Laboratories, Inc. operates through Life Science and Clinical Diagnostics segments, manufacturing and distributing a wide range of reagents, laboratory instruments, and test systems for research techniques, biopharmaceutical production, and clinical laboratories. The Life Science segment focuses on proteomics, genomics, biopharmaceutical production, cellular biology, and food safety, serving various industries and research organizations. The Clinical Diagnostics segment offers test systems, informatics systems, test kits, and quality controls for clinical laboratories, addressing specific niches within the in vitro diagnostics test market. The company generates revenue through direct sales, distributors, agents, brokers, and resellers.